The Combating Illicit Xylazine Act (H.R. 1266/S. 545) has just been reintroduced in Congress. Please take a moment to share the language and link below with your members to message their lawmakers and help build momentum for the legislation in Congress.
The AVMA built tremendous support last Congress for the Combating Illicit Xylazine Act, which would provide the Drug Enforcement Administration (DEA) resources to help stop the public health crisis of illicit xylazine while maintaining current veterinary access to this important animal sedative. Message your member of Congress by clicking here: https://avmacan.avma.org/campaign/110028/